A novel therapeutic agent for amyotrophic lateral sclerosis...

Details A novel therapeutic agent for amyotrophic lateral sclerosis... A novel therapeutic agent for amyotrophic lateral sclerosis...

A - Human Necessities

61

K

A61K 31/4152 (2006.01) A61P 21/00 (2006.01) C07D 231/26 (2006.01)

Patent

CA 2555457

There is provided a medicament for treating amyotrophic lateral sclerosis (ALS) or symptoms caused by ALS and/or suppressing the progression thereof, which is characterized in the usage, dosage and administration period of the pyrazolone derivative represented by the following formula (wherein each symbol indicates the same meaning as that defined in the specification): (see formula I)

Médicament pour le traitement de et/ou empêchant la progression de la sclérose latérale amyotrophique (SLA) ou de maladies imputables à la SLA, caractérisé par un procédé d~utilisation d~un dérivé de pyrazolone représenté par la formule suivante (dans laquelle les symboles sont les mêmes que ceux définis dans la description) et par la dose du dérivé et la période d~administration de celui-ci. [Formule chimique 1] (I)

Affiliated with

Also associated with

Rating

A novel therapeutic agent for amyotrophic lateral sclerosis... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A novel therapeutic agent for amyotrophic lateral sclerosis..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A novel therapeutic agent for amyotrophic lateral sclerosis... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1875964